Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab for Aspirin Intolerance in AERD
NCT04442256Phase 4Unknown
- Sponsor
- Medical University of Vienna
- Start
- Jun 2020
- Primary completion
- Dec 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of dupilumab in Aspirin Exacerbated Respiratory Disease (AERD), sponsored by Medical University of Vienna. Status: unknown.
02
Drugs
03
Conditions
Aspirin Exacerbated Respiratory Disease (AERD)
Beyond the preview
Go deeper on NCT04442256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04442256.